DOJ Focuses on Healthcare Fraud Claims Involving Amniotic Wound Allografts

The U.S. Department of Justice continues to increase its enforcement efforts involving healthcare fraud and False Claims Act violations. One area receiving heightened attention is the use of amniotic wound allografts and other advanced wound care products billed to Medicare and other federal healthcare programs.

DOJ healthcare fraud claims

According to a recent Department of Justice press release, federal prosecutors announced criminal charges against numerous individuals and organizations as part of a nationwide healthcare fraud takedown. Among the alleged schemes were fraudulent billing practices involving amniotic wound allografts, medically unnecessary treatments, and improper financial arrangements that resulted in billions of dollars in alleged false claims submitted to government healthcare programs.

Siro Smith Dickson is actively investigating healthcare fraud schemes involving amniotic wound allografts and other advanced wound care products. Individuals with knowledge of inflated pricing, false billing practices, illegal kickbacks, or other fraud involving government healthcare programs may have important rights under the False Claims Act. If you have identified healthcare fraud or other fraud in other government payment programs, please contact Siro Smith Dickson Partner, Eric W. Smith for a free and confidential consultation.

What Are Amniotic Wound Allografts?

Amniotic wound allografts are biologic products derived from donated human tissue and are designed to promote healing for certain chronic or difficult-to-treat wounds. These products have legitimate medical applications when used appropriately. However, because they can be expensive and are often reimbursed through federal healthcare programs, they have become an area of increased scrutiny by federal investigators.

The Department of Justice has emphasized that suspected fraud involving advanced wound care products can result in significant financial losses to Medicare and other taxpayer-funded healthcare programs while potentially exposing patients to medically unnecessary treatments.

DOJ Enforcement Highlights Common Healthcare Fraud Concerns

According to the DOJ, healthcare fraud investigations may involve allegations such as:

  • Billing Medicare or other government healthcare programs for medically unnecessary procedures
  • Inflated pricing of amniotic wound allografts or other advanced wound care products
  • Illegal kickbacks or financial incentives tied to product referrals or utilization
  • False or misleading reimbursement claims submitted to federal healthcare programs
  • Improper physician referral arrangements
  • Conduct that may violate the False Claims Act or the Anti-Kickback Statute

While every investigation is unique, these allegations illustrate the government’s continued commitment to identifying and pursuing fraud involving federally funded healthcare programs.

Who May Have Information About Healthcare Fraud?

Many successful False Claims Act investigations begin when individuals with firsthand knowledge report suspected fraud. People who may become aware of questionable billing or reimbursement practices include:

  • Physicians and surgeons
  • Nurses and wound care specialists
  • Medical sales representatives
  • Billing and coding professionals
  • Laboratory employees
  • Practice managers
  • Hospital administrators
  • Pharmaceutical or medical device employees
  • Compliance officers and other healthcare professionals

Federal law may provide protections for eligible whistleblowers who report fraud involving government healthcare programs.

How Whistleblowers Help Protect Federal Healthcare Programs

The False Claims Act allows private individuals with knowledge of fraud involving federal funds to file qui tam actions on behalf of the United States in appropriate circumstances. Many significant healthcare fraud investigations originate with information provided by whistleblowers who recognize improper billing practices, kickback arrangements, inflated pricing, or other conduct that may violate federal law.

By bringing suspected fraud to light, whistleblowers can help protect taxpayer dollars, promote compliance within the healthcare industry, and support the integrity of federal healthcare programs.

Contact Siro Smith Dickson

If you have information regarding potential fraud involving amniotic wound allografts, advanced wound care products, Medicare billing, or other healthcare fraud schemes, understanding your legal rights is an important first step.

Visit our Whistleblower Attorneys page to learn more about the False Claims Act and whistleblower protections. If you believe you have firsthand knowledge of healthcare fraud involving government programs, contact Attorney Eric W. Smith to discuss your situation confidentially.

Disclaimer: This article summarizes information contained in a public announcement issued by the U.S. Department of Justice. The referenced criminal charges are allegations, and all defendants are presumed innocent unless and until proven guilty in a court of law. This article is provided for informational purposes only.